WO2016034100A1 - 一种电雾化水香烟烟液及包含该烟液的电雾化水香烟 - Google Patents

一种电雾化水香烟烟液及包含该烟液的电雾化水香烟 Download PDF

Info

Publication number
WO2016034100A1
WO2016034100A1 PCT/CN2015/088730 CN2015088730W WO2016034100A1 WO 2016034100 A1 WO2016034100 A1 WO 2016034100A1 CN 2015088730 W CN2015088730 W CN 2015088730W WO 2016034100 A1 WO2016034100 A1 WO 2016034100A1
Authority
WO
WIPO (PCT)
Prior art keywords
electronic cigarette
ginsenoside
cigarette liquid
parts
present
Prior art date
Application number
PCT/CN2015/088730
Other languages
English (en)
French (fr)
Inventor
黄玉岭
Original Assignee
美国豪顿水香烟科技（香港）有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美国豪顿水香烟科技（香港）有限公司 filed Critical 美国豪顿水香烟科技（香港）有限公司
Publication of WO2016034100A1 publication Critical patent/WO2016034100A1/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors

Definitions

  • the invention belongs to the technical field of electronic cigarettes, and particularly relates to an electronic cigarette liquid and an electronic cigarette containing the same.
  • Tobacco has been introduced to China since the mid-16th century and has a history of more than 400 years. At present, there are about 300 million adults in China who are smokers, and more than 700 million people are affected by secondhand smoke. As we all know, smoking is harmful to health, it will induce a variety of diseases, such as: lung cancer, bronchitis, myocardial infarction, digestive system damage, nerve damage, etc.; and the tar, nitrosamines, carbon monoxide, radioactive substances, etc. contained in the smoke generated by burning cigarettes It is even more damaging to the smoker itself and the people around it.
  • diseases such as: lung cancer, bronchitis, myocardial infarction, digestive system damage, nerve damage, etc.
  • the electronic cigarette includes a tobacco rod, a nebulizer, and a battery assembly.
  • the principle is that the liquid is atomized by heating and directly enters the respiratory tract of the smoker; no burning, no ash is generated, and second-hand smoke is not formed.
  • the key to the taste of e-cigarettes is the composition of the liquid smoke; in order to simulate the aroma and taste of ordinary cigarettes as much as possible, a certain amount of nicotine has to be added to the electronic cigarette liquid currently sold on the market; and nicotine harms the central nervous system, Peripheral nervous system, accessory kidney medulla, etc.
  • the electronic cigarette prepared by the electronic cigarette liquid provided by the invention can not only satisfy the e-cigarette taste, but also improve the comprehensive immunity of the human body, thereby reducing the harm of smoking, gradually achieving the purpose of quitting smoking, and the health of hundreds of millions of smokers.
  • the present invention adopts the following technical solutions:
  • the present invention provides an electronic cigarette liquid comprising a saponin compound, a tobacco flavor, and a solvent.
  • the saponin compound in the electronic cigarette liquid provided by the present invention is ginsenoside Ra 1 , ginsenoside Ra 2 , ginsenoside Ra 3 , ginsenoside Rb 1 , ginsenoside Rb 2 , ginsenoside Rc, ginsenoside Rd, Ginsenoside Re, ginsenoside Rf, ginsenoside Rg 1 , ginsenoside Rg 2 , ginsenoside Rg 3 , ginsenoside Rh 1 , ginsenoside Rh 2 , ginsenoside Rs 1 , ginsenoside Rs 2 , ginsenoside Rs 3 , ginsenoside One or a mixture of two or more of F 1 , ginsenoside F 2 , ginsenoside F 3 , ginsenoside F 5 , ginsenoside R 0 , ginsenoside IH901, ginsenoside RAO or ginsenoside F 11
  • the saponin compound is provided by the American ginseng extract.
  • the raw material for preparing the American ginseng extract is one of the fermented material of the stem, leaf, root, rhizome, flower, fruit or American ginseng of the ginseng. kind or more.
  • the raw material for preparing the American ginseng extract is one or more of the stem, leaf, root, rhizome, flower or fruit of the American ginseng. .
  • the raw material for preparing the American ginseng extract is specifically one or more of the stem, leaf, root or rhizome of the American ginseng.
  • the preparation method of the American ginseng extract comprises:
  • the volume ratio of Citi participates in ethanol water is 1: (4-6). In some embodiments of the invention, the volume ratio of Citi to ethanol water is 1:5.
  • the content of ethanol in the ethanol water is 50% to 80% by volume.
  • the heating temperature is 65 ° C to 75 ° C. In still other embodiments of the invention, the temperature of the heating is 70 °C.
  • the heating time is 4 h to 10 h. In still other embodiments of the invention, the heating time is 6 h.
  • the preparation method of the American ginseng extract comprises:
  • the ammonium sulfate in the ammonium sulfate aqueous solution composed of ammonium sulfate and water is contained in an amount of 3% by mass.
  • the volume ratio of the Citi participating water is 1: (3-6). In some embodiments of the invention, the volume ratio of Citi participation water is 1:5.
  • the relative density of the obtained extract is 1.15 (50 ° C thermal measurement).
  • the drying is spray drying.
  • the pH of the filtrate is adjusted to 10 to 12 after collecting the filtrate and before passing through the resin column.
  • the preparation method of the American ginseng extract is obtained by fermentation of American ginseng, and the specific method is:
  • the raw materials and culture medium of the American ginseng are taken, mixed, and inoculated with Aspergillus niger. After fermentation, the fermentation broth is recovered, extracted and/or purified, and obtained.
  • the ginseng raw material used is the stem, leaf, root, rhizome, flower, and fruit of the ginseng. Or a mixture of one or more of the saponin compounds extracted from any part of the ginseng.
  • the saponin compound can be any combination of total saponins, monomeric saponins or any saponin.
  • the American ginseng extract included in the electronic cigarette liquid provided by the present invention can be obtained according to the preparation method provided by the present invention, but is not limited to the preparation method provided by the present invention.
  • the present invention provides an electronic cigarette liquid in which the content of the saponin compound is from 0.734 g/L to 660 g/L.
  • the tobacco flavor is a tobacco extract and/or a synthetic flavor.
  • the tobacco flavor is a tobacco extract.
  • the tobacco flavor is a synthetic fragrance.
  • the tobacco flavor in the present invention is a substance capable of producing a tobacco flavor, and includes a tobacco extract or other substance which can produce a tobacco flavor.
  • other substances which can produce tobacco aroma are referred to as synthetic fragrances, which include a single fragrance or a combination of more fragrances.
  • the raw material for preparing the tobacco extract is a Solanaceae Nicotiana L. plant.
  • the raw material for the preparation of the tobacco extract in some embodiments of the invention is the leaves of the Solanaceae plant.
  • the method for preparing the tobacco extract comprises:
  • the drying temperature is 30 ° C to 50 ° C. In some embodiments of the invention, the drying temperature is 40 °C.
  • the volume ratio of the dried Solanaceae plant to water is 1: (4-6). In some embodiments of the invention, the volume ratio of the dried Solanaceae plant to water is 1:5.
  • the temperature of the immersion is 15 ° C to 30 ° C.
  • the immersion time is 40h to 55h.
  • the extraction is extraction or ultrasonic extraction.
  • the tobacco extract in the electronic cigarette liquid provided by the present invention can be obtained according to the preparation method provided by the present invention, but is not limited to the preparation method provided by the present invention.
  • the synthetic fragrance is composed of coumarin, rutin, quercetin, chlorogenic acid, isovaleric acid, ⁇ -methyl valeric acid, and geranium. Composition of aldehyde, catechol and solanesol.
  • the coumarin, rutin, quercetin, chlorogenic acid, isovaleric acid, ⁇ -methyl valeric acid, and fragrant are synthesized in the synthetic fragrance.
  • the mass ratio of leaf aldehyde, catechol, and solanesol is (1 to 10): (1 to 10): (0.1 to 1): (1 to 3): (1 to 3): (1 to 3): (1 to 3): (1 to 5): (1 to 5): (1 to 5).
  • the solvent in the electronic cigarette liquid provided by the present invention is an organic solvent. More preferably, the solvent in the electronic cigarette liquid provided by the present invention is one or a mixture of two or more of sorbitol, glycerin, propylene glycol, and water. In some embodiments of the invention, in the electronic cigarette liquid provided by the present invention, the solvent is glycerol and/or propylene glycol.
  • the electronic cigarette liquid provided by the present invention comprises 0.0734 to 66 parts by weight of the saponin compound, 1 to 70 parts by weight of the tobacco flavor, and 26.7 to 96.5 parts by weight of the solvent.
  • the content of the saponin compound in the electronic cigarette liquid provided by the present invention is 0.0734 parts by weight, 0.387 parts by weight, 0.505 parts by weight, 0.765 parts by weight, 0.81 parts by weight, 1 part by weight, 4.03 by weight. Parts, 4.57 parts by weight, 18.27 parts by weight, 66 parts by weight.
  • the content of the tobacco flavor in the electronic cigarette liquid provided by the present invention is 1 part by weight, 5 parts by weight, 20 parts by weight, 25 parts by weight, 30 parts by weight, 70 parts by weight.
  • the electronic cigarette liquid provided by the present invention has a solvent content of 26.7 parts by weight, 66.7 parts by weight, 71.7 parts by weight, 76.5 parts by weight, and 96.5 parts by weight.
  • the invention also provides an electronic cigarette comprising the following components: a tobacco rod, an atomizer, a battery assembly; the electronic cigarette liquid is placed in the atomizer;
  • the electronic cigarette liquid includes a saponin compound, a tobacco flavor, and a solvent.
  • the electronic cigarette liquid provided by the present invention when the electronic cigarette liquid provided by the present invention is integrated with the tobacco rod, the atomizer, and the battery, the electronic cigarette is obtained, which is called “water cigarette”. Accordingly, the electronic cigarette liquid is also referred to as “water cigarette” smoke liquid in the present application.
  • the invention provides an electronic cigarette liquid and an electronic cigarette comprising the same.
  • the electronic cigarette liquid provided by the present invention includes a saponin compound, a tobacco flavor, and a solvent.
  • the experimental results confirmed that the electronic cigarette prepared by the electronic cigarette liquid provided by the invention has good atomization effect, pure taste and small throat irritation; and the electronic cigarette prepared by using the electronic cigarette liquid can be beneficial to lung yin, Clearing the fire, lowering blood pressure, lowering blood fat, improving anti-oxidation ability, eliminating fatigue, calming and concentrating, and enhancing memory can improve the comprehensive ability of human immunity, thereby reducing the harm of smoking and gradually achieving the purpose of quitting smoking.
  • Figure 1 shows the qualitative test results of the extract of American Ginseng obtained by the preparation of each example, wherein Rb 1 represents ginsenoside Rb 1 standard, Rc represents ginsenoside Rc standard, Re represents ginsenoside Re standard, and Rd represents ginsenoside Rd
  • the standard Rg 1 represents ginsenoside Rg 1 standard, Rh 1 represents ginsenoside Rh 1 standard, Rg 3 represents ginsenoside Rg 3 standard, and Rh 2 represents ginsenoside Rh 2 standard; wherein 1 represents the preparation of Example 1.
  • the obtained American ginseng extract 2 represents the American ginseng extract obtained in the preparation of Example 2
  • 3 represents the American ginseng extract obtained in the preparation of Example 3
  • 4 represents the American ginseng extract obtained in the preparation of Example 4
  • 5 represents an example.
  • the obtained American ginseng extract was prepared
  • 7 represents the American ginseng extract obtained in the preparation of Example 7
  • 8 represents the American ginseng extract obtained in the preparation of Example 8.
  • the invention discloses an electronic cigarette liquid and an electronic cigarette containing the same, and those skilled in the art can learn from the contents of the paper and appropriately improve the process parameters. It is to be understood that all such alternatives and modifications are obvious to those skilled in the art and are considered to be included in the present invention.
  • the method and the application of the present invention have been described by the preferred embodiments, and it is obvious that the method and application described herein may be modified or appropriately modified and combined without departing from the scope of the present invention. The technique of the present invention is applied.
  • the reagents and raw materials used in the electronic cigarette liquid of the present invention and the electronic cigarette containing the same are commercially available.
  • the obtained American ginseng extract was prepared, 3 represents the American ginseng extract obtained in the preparation of Example 3, 4 represents the American ginseng extract obtained in the preparation of Example 4, 5 represents the American ginseng extract obtained in Example 5, and 7 represents the implementation.
  • Example 7 The obtained American ginseng extract was prepared, and 8 represents the American ginseng extract obtained in Example 8.
  • the saponin compounds in the American ginseng extract are mainly ginsenosides Rb 1 , Rc, Re, Rd, Rg 1 and Rh 1 .
  • the mass percentage of the saponin compound in the American ginseng extract was 81.02%, and the main components were ginsenoside Rb 1 , Rc, Re, Rd, Rg. 1 , Rh 1 (see Figure 1).
  • the mass percentage of the saponin compound in the American ginseng extract was 91.33%, and the main components were ginsenoside Rb 1 , Rc, Re, Rd, Rg 1 . , Rh 1 (see Figure 1).
  • the mass percentage of the saponin compound in the American ginseng extract was 80.56%, and the main components were ginsenoside Rb 1 , Rc, Re, Rd, Rg 1 , Rh 1 ( see picture 1).
  • the cultured fermentation broth was autoclaved at 121 ° C for 30 min, and an equal volume of water-saturated n-butanol was added, ultrasonically extracted for 30 min, filtered, centrifuged (5000 r/min, 10 min), and the supernatant was taken. The supernatant was concentrated under reduced pressure, and dried with hot air to obtain an extract of American ginseng.
  • the mass percentage of the saponin compound in the American ginseng extract is 10.09%, and the main components are ginsenoside Rb 1 , Rc, Re, Rd, Rg. 1 , Rg 3 , Rh 1 , Rh 2 (see Figure 1).
  • the electronic cigarette liquids obtained in Examples 1 to 10, the prepared electronic cigarette liquid, and the control group were respectively taken.
  • the electronic cigarette prepared by the electronic cigarette liquid obtained by the present invention from the first embodiment to the tenth embodiment was used as an experimental group, and the electronic cigarette made of the electronic cigarette liquid without adding the American ginseng extract was used as a control group.
  • the obtained e-cigarette samples were evaluated by 20 professional technicians with national or provincial cigarette sensory quality evaluation qualification certificates, and then the sensory quality evaluation was carried out.
  • the sensory quality evaluation standards are shown in Table 1.
  • the results of the sucking test are shown in Table 2.
  • Example 2 30.15 4.85 19.60 23.05 8.30 85.95
  • Example 3 31.30 5.15 19.00 24.15 8 87.60
  • Example 4 30.85 5.20 18.75 23.55 8 86.35
  • Example 5 30.55 5.45 19.00 23.70 8 86.70
  • Example 6 31.20 5.15 18.60 24.00 8 86.95
  • Example 7 31.60 5.25 18.55 23.90 8 87.30
  • Example 8 30.15 5.55 18.95 23.45 8 86.10 Example 9 29.75 4.75 18.95 23.40 8.20 85.05
  • Example 10 30.25 5.65 18.25 24.00 8 86.15
  • the aroma and aftertaste of the electronic cigarette products of the experimental group (that is, the electronic cigarettes prepared by the electronic cigarette liquids prepared by the first to the tenth embodiments of the present invention) were further improved compared with the control group.
  • the irritancy was significantly reduced, and the difference was significant (P ⁇ 0.05), which significantly improved the irritation of the electronic cigarette to the throat.
  • the control results of the control group and the experimental group were equivalent, indicating that the addition of the ginseng extract in the electronic cigarette liquid did not affect the atomization effect.
  • the electronic cigarette liquid provided by the invention has good atomization effect, pure taste, and significantly reduces the irritation to the throat.
  • the electronic cigarette made of the electronic cigarette liquid prepared by the embodiment 1 of the present invention was taken into consideration to affect the normal function of the human body.
  • the subject was 1.5 mL per day for 3 months.
  • the subject's indicators related to the cardiovascular system, blood system, and antioxidant capacity were measured before and after 3 months of use of the electronic cigarette provided by the present invention: blood pressure, total cholesterol Alcohol, triglyceride, low density lipoprotein, high density lipoprotein, malondialdehyde, superoxide dismutase, glutathione peroxidase, lipid peroxide.
  • the number and function of macrophages were tested, and an in vitro lymphocyte proliferation test was performed to test the body immunity.
  • Example 2 to Example 10 Taking the electronic cigarettes prepared by the preparation of the electronic cigarette liquids obtained in Example 2 to Example 10, according to the same experimental method, the influence of the electronic cigarette liquid provided by the present invention on the normal function of the human body was examined, and similar experimental results were obtained. That is, after the electronic cigarette liquid obtained by using the inventive examples 2 to 10, the blood pressure of the subject was significantly improved, the blood lipid was significantly improved, the antioxidant ability was remarkably improved, and the comprehensive immunity was significantly improved.
  • the long-term use of the electronic cigarette prepared by using the electronic cigarette liquid provided by the invention can lower blood pressure, lower blood fat, resist fatigue, delay aging, and achieve the effect of improving comprehensive immunity.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Fats And Perfumes (AREA)

Abstract

一种电子烟烟液及包含该烟液的电子烟。电子烟烟液包括皂苷类化合物、烟草香料和溶剂。电子烟烟液制备而成的电子烟既能够满足电子烟口感，又能提高人体免疫综合能力，从而降低吸烟的危害。

Description

一种可以提高人体免疫力的电雾化水香烟烟液及包含该烟液的电雾化水香烟
本申请要求于2014年09月03日提交中国专利局、申请号为201410445720.9、发明名称为“一种可以提高人体免疫力的电雾化水香烟烟液及包含该烟液的电雾化水香烟”的中国专利申请的优先权，其全部内容通过引用结合在本申请中。
技术领域
本发明属于电子烟技术领域，特别涉及一种电子烟烟液及包含该烟液的电子烟。
背景技术
烟草自16世纪中叶传入中国，距今已有400多年的历史。目前，我国约有3亿成年人是烟民，超过7亿人受二手烟的影响。众所周知，吸烟有害健康，会诱发多种疾病，如：肺癌、支气管炎、心肌梗塞、消化系统损伤、神经损伤等；而点燃香烟产生的烟雾中含有的焦油、亚硝胺、一氧化碳、放射性物质等，更对吸烟者本身及其周围的人们产生极大损害。
随着全球控烟运动的不断发展、《中国烟草控制规划(2012-2015》的出台、国务院公共场所禁烟的颁布等，吸烟越来越不得人心。但是，由于长期形成的吸烟文化、吸烟社会性功能、吸烟成瘾等原因，禁烟之路必定漫长。基于此类原因，各种模拟卷烟的产品相继出现，其中以电子烟(电雾化烟)最为盛行。
电子烟包括烟杆、雾化器、电池组件，其原理是通过加热将烟液雾化，直接进入吸烟者呼吸道；不燃烧、不产生烟灰、不形成二手烟。电子烟的口味，关键在于烟液的成分；为了尽可能地模拟普通香烟的香气、口味，目前市场上所售的电子烟烟液中不得不加入一定量的尼古丁；而尼古丁危害中枢神经系统、周边神经系统、副肾髓质等。现有技术中，通过向电子烟烟液中添加多种中药材，如：人参、黄芪、五味子、枸杞、淫羊藿、当归、白芷、鹿茸、桔梗、三七、曼陀罗、连翘、天冬、柴胡等，来试图改 善这一缺点，但是，这些电子烟的实用效果平平，并未引起关注。所以，还需要提供新的电子烟烟液，以实现在满足电子烟口感的情况下，提高电子烟的使用安全性。
发明内容
本发明的目的在于提供一种电子烟烟液及包含该烟液的电子烟。本发明提供的电子烟烟液制备而成的电子烟既能满足电子烟口感，又能够提高人体综合免疫能力，从而降低吸烟的危害，逐步达到戒烟的目的，还几亿烟民健康的体魄。
为了实现本发明的发明目的，本发明采用如下的技术方案：
本发明提供了一种电子烟烟液，其包括皂苷类化合物、烟草香料和溶剂。
优选地，本发明提供的电子烟烟液中的皂苷类化合物为人参皂苷Ra1、人参皂苷Ra2、人参皂苷Ra3、人参皂苷Rb1、人参皂苷Rb2、人参皂苷Rc、人参皂苷Rd、人参皂苷Re、人参皂苷Rf、人参皂苷Rg1、人参皂苷Rg2、人参皂苷Rg3、人参皂苷Rh1、人参皂苷Rh2、人参皂苷Rs1、人参皂苷Rs2、人参皂苷Rs3、人参皂苷F1、人参皂苷F2、人参皂苷F3、人参皂苷F5、人参皂苷R0、人参皂苷IH901、人参皂苷RAO或拟人参皂苷F11中的一种或两者以上混合物。
在本发明的一些实施例中，本发明提供的电子烟烟液中，皂苷类化合物由花旗参提取物提供。
在本发明的一些实施例中，本发明提供的电子烟烟液中，用于制备花旗参提取物的原料为花旗参茎、叶、根、根茎、花、果实或花旗参发酵物质中的一种或多种。在本发明的另外一些实施例中，本发明提供的电子烟烟液中，用于制备花旗参提取物的原料为花旗参茎、叶、根、根茎、花或果实中的一种或多种。在本发明的另外一些实施例中，用于制备花旗参提取物的原料具体为花旗参茎、叶、根或根茎中的一种或多种。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法包括：
取花旗参与乙醇水溶液混合，经加热、浸泡、过滤后，收集滤液，经浓缩、干燥，即得。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法中，花旗参与乙醇水的体积比为1:(4～6)。在本发明的一些实施例中，花旗参与乙醇水的体积比为1:5。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法中，以体积百分比计，乙醇水中乙醇的含量为50％～80％。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法中，加热的温度为65℃～75℃。在本发明的另外一些实施例中，加热的温度为70℃。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法中，加热的时间为4h～10h。在本发明的另外一些实施例中，加热的时间为6h。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法包括：
取花旗参与水混合，经加热，过滤后，收集滤液，过大孔树脂，用体积百分含量为75％～80％的乙醇水溶液洗脱，收集洗脱组分，经浓缩、干燥，即得。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法中，在花旗参与水混合时，还可以加入硫酸铵，加入硫酸铵有利于提高花旗参提取物中皂苷类化合物的收率。在本发明的另外一些实施例中，本发明提供的另外一些实施例中，以质量体积百分比计，硫酸铵与水组成的硫酸铵水溶液中硫酸铵的含量为3％。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法中，花旗参与水的体积比为1:(3～6)。在本发明的一些实施例中，花旗参与水的体积比为1:5。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法中，浓缩至所得浸膏的相对密度为1.15(50℃热测)。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法中，干燥为喷雾干燥。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法中，收集滤液之后、过树脂柱之前，调节滤液的pH值至10～12。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物的制备方法，为由花旗参发酵获得，具体方法为：
取花旗参原料、培养基，混合后，接种黑曲霉，经发酵后，回收发酵液，提取和/或纯化，即得。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，花旗参提取物由花旗参发酵获得时，所用花旗参原料为花旗参茎、叶、根、根茎、花、果实，或者从花旗参任意部位提取的皂苷类化合物中的一种或两者以上混合物。该皂苷类化合物可以是总皂苷、单体皂苷或任意皂苷的任意组合。
本发明提供的电子烟烟液中所包括的花旗参提取物可以按照本发明提供的制备方法制备获得，但不局限于本发明提供的制备方法。
优选地，本发明提供的电子烟烟液，其中皂苷类化合物的含量为0.734g/L～660g/L。
优选地，本发明提供的电子烟烟液中，烟草香料为烟草提取物和/或合成香料。在本发明的一些实施例中，烟草香料为烟草提取物。在本发明的另外一些实施例中烟草香料为合成香料。
本发明中的烟草香料为能够产生烟草香味的物质，其包括烟草提取物或者其他可以产生烟草香味的物质。在本发明中，其他可以产生烟草香味的物质被称为合成香料，其包括单一香料或者更多种香料的组合。
本发明提供的电子烟烟液中，制备烟草提取物的原料为茄科(Solanaceae)烟草属(Nicotiana L.)植物。在本发明的一些实施例中制备烟草提取物的原料为茄科烟草属植物的叶。
在本发明的一些实施例中，本发明提供的电子烟烟液中，烟草提取物的制备方法包括：
取茄科烟草属植物，经干燥后，与水混合，经浸泡，提取，过滤后，收集滤液，即得。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，烟草提取物的制备方法中，干燥的温度为30℃～50℃。在本发明的一些实施例中，干燥的温度为40℃。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，烟草提取物的制备方法中，干燥后的茄科烟草属植物与水的体积比为1:(4～6)。在本发明的一些实施例中，干燥后的茄科烟草属植物与水的体积比为1:5。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，烟草提取物的制备方法中，浸泡的温度为15℃～30℃。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，烟草提取物的制备方法中，浸泡的时间为40h～55h。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，烟草提取物的制备方法中，提取为浸提或超声波萃取。
本发明提供的电子烟烟液中的烟草提取物可以按照本发明提供的制备方法制备获得，但不局限于本发明提供的制备方法。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，合成香料由香豆素、芸香苷、槲皮素、绿原酸、异戊酸、β-甲基戊酸、香叶醛、儿茶酚、茄尼醇组成。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，合成香料中香豆素、芸香苷、槲皮素、绿原酸、异戊酸、β-甲基戊酸、香叶醛、儿茶酚、茄尼醇的质量比为(1～10):(1～10):(0.1～1):(1～3):(1～3):(1～3):(1～5):(1～5):(1～5)。
优选地，本发明提供的电子烟烟液中的溶剂为有机溶剂。更为优选地，本发明提供的电子烟烟液中的溶剂为山梨醇、丙三醇、丙二醇、水中的一种或两者以上混合物。在本发明的一些实施例中，本发明提供的电子烟烟液中，溶剂为丙三醇和/或丙二醇。
优选地，本发明提供的电子烟烟液，包括0.0734～66重量份的所述皂苷类化合物、1～70重量份的所述烟草香料、26.7～96.5重量份的所述溶剂。
在本发明的一些实施例中，本发明提供的电子烟烟液中皂苷类化合物的含量为0.0734重量份、0.387重量份、0.505重量份、0.765重量份、0.81重量份、1重量份、4.03重量份、4.57重量份、18.27重量份、66重量份。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中烟草香料的含量为1重量份、5重量份、20重量份、25重量份、30重量份、70重量份。
在本发明的另外一些实施例中，本发明提供的电子烟烟液中，溶剂的含量为26.7重量份、66.7重量份、71.7重量份、76.5重量份、96.5重量份。
本发明还提供了一种电子烟，其包括以下构件：烟杆、雾化器、电池组件；电子烟烟液放置于雾化器之中；
该电子烟烟液包括皂苷类化合物、烟草香料和溶剂。
在本发明中，当利用本发明提供的电子烟烟液与烟杆、雾化器、电池集成后，即获得电子烟，我们称之为“水香烟”。相应地，该电子烟烟液在本申请中也被称为“水香烟”烟液。
本发明提供了一种电子烟烟液及包含该烟液的电子烟。本发明提供的电子烟烟液包括皂苷类化合物、烟草香料和溶剂。实验结果证实，本发明提供的电子烟烟液制备而成的电子烟的雾化效果好、口感纯正、对咽喉刺激小；且使用该电子烟烟液制备而成的电子烟可以有益肺阴、清虚火、降血压、降血脂、提高抗氧化能力、消除疲劳、静心凝神、增强记忆力，能够提高人体免疫综合能力，从而降低吸烟的危害，逐步达到戒烟的目的。
附图说明
图1示各个实施例制备获得的花旗参提取物的定性检测结果，其中Rb1代表人参皂苷Rb1标准品，Rc代表人参皂苷Rc标准品，Re代表人参皂苷Re标准品、Rd代表人参皂苷Rd标准品、Rg1代表人参皂苷Rg1标 准品、Rh1代表人参皂苷Rh1标准品、Rg3代表人参皂苷Rg3标准品、Rh2代表人参皂苷Rh2标准品；其中1代表实施例1制备获得的花旗参提取物、2代表实施例2制备获得的花旗参提取物、3代表实施例3制备获得的花旗参提取物、4代表实施例4制备获得的花旗参提取物、5代表实施例5制备获得的花旗参提取物，7代表实施例7制备获得的花旗参提取物，8代表实施例8制备获得的花旗参提取物。
具体实施方式
本发明公开了一种电子烟烟液及包含该烟液的电子烟，本领域技术人员可以借鉴本文内容，适当改进工艺参数实现。特别需要指出的是，所有类似的替换和改动对本领域技术人员来说是显而易见的，它们都被视为包括在本发明。本发明的方法及应用已经通过较佳实施例进行了描述，相关人员明显能在不脱离本发明内容、精神和范围内对本文所述的方法和应用进行改动或适当变更与组合，来实现和应用本发明技术。
本发明提供的一种电子烟烟液及包含该烟液的电子烟中所用到的试剂和原料均可由市场购得。
下面结合实施例，进一步阐述本发明：
实施例1电子烟烟液的制备
(1)花旗参提取物的制备：将花旗参根部切成0.5～1.0cm的小段，与5倍体积的体积百分含量为75％的乙醇混合，之后于70℃条件下保温6小时，保温期间不断搅拌；静置、取上清；所得沉淀与5倍体积的体积百分含量为75％的乙醇混合，之后进行提取，如此重复3次。合并上清液，减压浓缩，热风吹干，得到花旗参提取物。
(2)花旗参提取物中皂苷类化合物的定性检测(定性检测方法)：
采用薄层层析法。取人参皂苷Rb1、Rc、Rd、Re、Rg1、Rg3、Rh1、Rh2各10mg，分别溶于2mL甲醇，制成标准品液。用微量点样器分别吸取标准品液以及花旗参提取物液，点于薄层层析板上，用风筒吹干，然后置于盛有展开剂[V(氯仿):V(甲醇):V(水)＝65:35:10(下层)]的层析缸中展 开，展开约距上边缘2～3mm时取出，挥干溶剂，喷10％H2SO4-乙醇溶液后，在105℃加热3min显色后观察。检测结果见图1，其中Rb1代表人参皂苷Rb1标准品，Rc代表人参皂苷Rc标准品，Re代表人参皂苷Re标准品、Rd代表人参皂苷Rd标准品、Rg1代表人参皂苷Rg1标准品、Rh1代表人参皂苷Rh1标准品、Rg3代表人参皂苷Rg3标准品、Rh2代表人参皂苷Rh2标准品；其中1代表实施例1制备获得的花旗参提取物、2代表实施例2制备获得的花旗参提取物、3代表实施例3制备获得的花旗参提取物、4代表实施例4制备获得的花旗参提取物、5代表实施例5制备获得的花旗参提取物，7代表实施例7制备获得的花旗参提取物，8代表实施例8制备获得的花旗参提取物。
根据样品点与标准品位置的比较可知(见图1)，该花旗参提取物中皂苷类化合物主要为人参皂苷Rb1、Rc、Re、Rd、Rg1、Rh1。
(3)花旗参提取物中皂苷类化合物的质量百分比的测定(定量检测方法)：
a.标准曲线的绘制：精密称量人参皂苷Re对照品16.3mg，置于10mL容量瓶中，加入甲醇至刻度，摇匀，即得。分别精密量取人参皂苷Re标准品溶液10，20，40，60，80，100μL于具塞试管中，用甲醇定容到1mL，配成系列对照溶液。分别准确加入0.5mL 8％的香兰素乙醇溶液(用无水乙醇现配)、5mL 77％的硫酸溶液，混合均匀，置于60℃水浴上恒温10min，然后立即取出，放入冰水浴15min，取出放置至室温，显色溶液于544nm处测定吸光度，以吸光度(A)对皂苷类化合物浓度(C)作回归处理，得回归方程:C＝0.2305A-0.0045，r＝0.999。结果表明，人参皂苷Re在16.3～163μg范围内吸光度与浓度呈良好的线性关系。
b.取花旗参提取物0.5g，溶于5mL容量瓶中，取20μL溶液共3份，分别置于3个10mL磨口带塞试管中，按上述方法显色测定吸光度，由回归方程计算得到，该花旗参提取物中皂苷类化合物的平均质量百分比为7.34％。
(4)烟叶提取物的制备：将烟叶于40℃下烘干，冷却至室温，粉碎，与5倍体积的去离子水混合，15℃浸泡，不定期搅拌，48小时后抽滤，减压浓缩至1/2体积左右，得到烟叶提取物。
(5)电子烟烟液的制备：取所得花旗参提取物1份(相当于皂苷类化合物0.0734份，每份1g计)、所得烟叶提取物20份、丙三醇11.5份、丙二醇65份，混合均匀、充分溶解，即得电子烟烟液100mL，所得电子烟烟液中皂苷类化合物的含量为0.734g/L。本发明称之为“水香烟”烟液。
实施例2电子烟烟液的制备
(1)花旗参提取物的制备：将花旗参根部切成0.5～1.0cm的小段，与4倍体积的体积百分含量为80％的乙醇混合，之后于65℃条件下保温4小时，保温期间不断搅拌；静置、取上清；所得沉淀与4倍体积的体积百分含量为80％的乙醇混合，之后进行提取，如此重复3次。合并上清液，减压浓缩，热风吹干，得到花旗参提取物。按照实施例1提供的定性和定量检测方法进行定性和定量测定，得到：该花旗参提取物中皂苷类化合物的质量百分比为7.65％，主要成分为人参皂苷Rb1、Rc、Re、Rd、Rg1(见图1)。
(2)合成香料的制备：按照质量比为6:2:1:1:1:3:5:1:1；分别取香豆素、芸香苷、槲皮素、绿原酸、异戊酸、β-甲基戊酸、香叶醛、儿茶酚、茄尼醇，混合均匀，即得。
(3)电子烟烟液的制备：取所得花旗参提取物10份(相当于皂苷类化合物0.765份，每份1g计)、所得合成香料20份、去离子水5份、丙三醇11.5份、丙二醇80份，混合均匀、充分溶解，即得电子烟烟液100mL，所得电子烟烟液中皂苷类化合物的含量为7.65g/L。本发明称之为“水香烟”烟液。
实施例3电子烟烟液的制备
(1)花旗参提取物的制备：将花旗参根部切成0.5～1.0cm的小段，与6倍体积的体积百分含量为50％的乙醇混合，之后于75℃条件下保温 10小时，保温期间不断搅拌；静置、取上清；所得沉淀与6倍体积的体积百分含量为50％的乙醇混合，之后进行提取，如此重复3次。合并上清液，减压浓缩，热风吹干，得到花旗参提取物。按照实施例1提供的定性和定量检测方法进行定性和定量测定，得到：该花旗参提取物中皂苷类化合物的质量百分比为7.73％，主要成分为人参皂苷Rb1、Rc、Re、Rd、Rg1、Rh1(见图1)。
(2)烟叶提取物的来源：深圳市佩里沃生物科技有限公司。
(3)电子烟烟液的制备：取所得花旗参提取物5份(相当于皂苷类化合物0.387份，每份1g)、所得烟草提取物30份、去离子水5份、山梨醇6.7份、丙二醇55份，混合均匀、充分溶解，即得电子烟烟液100mL，所得电子烟烟液中皂苷类化合物的含量为3.87g/L。本发明称之为“水香烟”烟液。
实施例4电子烟烟液的制备
(1)花旗参提取物的制备：取花旗参茎叶，加5倍体积的蒸馏水，煎煮3次，每次3、3、2小时，分次过滤，合并滤液，静置24小时，取上清液，加氢氧化钠调节pH值至10，通过大孔树脂柱吸附，用水洗柱至中性后，用75％乙醇洗脱，洗脱液回收乙醇，浓缩至相对密度1.15(50℃热测)的浸膏，喷雾干燥，得到花旗参提取物。按照实施例1提供的定性和定量检测方法进行定性和定量测定，得到：该花旗参提取物中皂苷类化合物的质量百分比为81.02％，主要成分为人参皂苷Rb1、Rc、Re、Rd、Rg1、Rh1(见图1)。
(2)烟叶提取物的制备：将烟叶于30℃下烘干，冷却至室温，粉碎，与6倍体积的去离子水混合，30℃浸泡，不定期搅拌，40小时后抽滤，减压浓缩至1/2体积，得到烟叶提取物。
(3)电子烟烟液的制备：取所得花旗参提取物1份(相当于皂苷类化合物0.81份，每份1g)、所得烟叶提取物25份、去离子水5份、丙二醇60份、山梨醇6.7份，混合均匀、充分溶解，即得电子烟烟液100mL，所得电子烟烟液中皂苷类化合物的含量为8.1g/L。本发明称之为“水香烟”烟 液。
实施例5电子烟烟液的制备
(1)花旗参提取物的制备：取花旗参茎叶，加3倍体积的3％(W/V)硫酸铵溶液，煎煮3次，每次3、3、2小时，分次过滤，合并滤液，静置24小时，取上清液，加氢氧化钠调节pH值至12，通过大孔树脂柱吸附，用水洗柱至中性后，用80％乙醇洗脱，洗脱液回收乙醇，浓缩至相对密度1.15(50℃热测)的浸膏，喷雾干燥，得到花旗参提取物。按照实施例1提供的定性和定量检测方法进行定性和定量测定得到：该花旗参提取物中皂苷类化合物的质量百分比为91.33％，主要成分为人参皂苷Rb1、Rc、Re、Rd、Rg1、Rh1(见图1)。
(2)合成香料的制备：按照质量比为1:10:0.5:3:3:1:1:2:5；分别取香豆素、芸香苷、槲皮素、绿原酸、异戊酸、β-甲基戊酸、香叶醛、儿茶酚、茄尼醇，混合均匀，即得。
(3)电子烟烟液的制备：取所得花旗参提取物5份(相当于4.57份的皂苷类化合物，每份1g)、所得合成香料5份、去离子水15份、丙二醇70份、丙三醇11.5份，混合均匀、充分溶解，即得电子烟烟液100mL，所得电子烟烟液中皂苷类化合物的含量为45.7g/L。本发明称之为“水香烟”烟液。
实施例6电子烟烟液的制备
(1)花旗参提取物的制备：实施例5提供的制备方法制备获得，所得花旗参提取物中皂苷类化合物的质量百分比为91.33％，主要成分为人参皂苷Rb1、Rc、Re、Rd、Rg1、Rh1(见图1)。
(2)烟叶提取物的制备：将烟叶于50℃下烘干，冷却至室温，粉碎，与4倍体积的去离子水混合，25℃浸泡，不定期搅拌，55小时后抽滤，减压浓缩至1/2体积，得到烟叶提取物。
(3)电子烟烟液的制备：取所得花旗参提取物20份(相当于18.27份的皂苷类化合物，每份1g)、所得烟叶提取物20份、丙二醇65份、丙三醇11.5份，混合均匀、充分溶解，即得电子烟烟液100mL，所得电子烟烟液 中皂苷类化合物的含量为182.7g/L。本发明称之为“水香烟”烟液。
实施例7电子烟烟液的制备
(1)花旗参提取物的制备：取花旗参茎叶，加6倍体积的蒸馏水，煎煮3次，每次3、3、2小时，分次过滤，合并滤液，静置24小时，取上清液，加氢氧化钠调节pH值至11，通过大孔树脂柱吸附，用水洗柱至中性后，用78％乙醇洗脱，洗脱液回收乙醇，浓缩至相对密度1.15(50℃热测)的浸膏，喷雾干燥，得到花旗参提取物。按照实施例1提供的定性和定量检测方法测定得到：该花旗参提取物中皂苷类化合物的质量百分比为80.56％，主要成分为人参皂苷Rb1、Rc、Re、Rd、Rg1、Rh1(见图1)。
(2)烟草提取物的来源：广东华邦香料科技有限公司。
(3)电子烟烟液的制备：取所得花旗参提取物5份(相当于4.03份的皂苷类化合物，每份1g)、所得烟草提取物70份、去离子水5份、丙二醇15份、山梨醇6.7份，混合均匀、充分溶解，即得电子烟烟液100mL，所得电子烟烟液中皂苷类化合物的含量为40.03g/L。本发明称之为“水香烟”烟液。
实施例8电子烟烟液的制备
(1)花旗参提取物的制备：取花旗参根10g装于250mL锥形瓶中，加入20mL去离子水，封口，121℃高压蒸汽灭菌30min。冷却后于超净工作台中紫外灭菌30min后，接种黑曲霉(Aspergillus nige，来源于沂源康源生物科技有限公司)5mL，37℃恒温培养7d。将培养好的发酵液于121℃高压蒸汽灭菌30min，加入同等体积的水饱和正丁醇，超声萃取30min，过滤、离心(5000r/min，10min)，取上清。将上清液减压浓缩，热风吹干，得到花旗参提取物。按照实施例1提供的定性检测和定量检测方法进行定性和定量测定得到：该花旗参提取物中皂苷类化合物的质量百分比为10.09％，主要成分为人参皂苷Rb1、Rc、Re、Rd、Rg1、Rg3、Rh1、Rh2(见图1)。
(2)合成香料的制备：按照质量比为10:1:0.1:1:1:1:5:5:5；分别 取香豆素、芸香苷、槲皮素、绿原酸、异戊酸、β-甲基戊酸、香叶醛、儿茶酚、茄尼醇，混合均匀，即得。
(3)电子烟烟液的制备：取所得花旗参提取物5份(相当于皂苷类化合物0.505份，每份1g)、所得合成香料5份、去离子水15份、丙二醇70份、丙三醇11.5份，混合均匀、充分溶解，即得电子烟烟液100mL，所得电子烟烟液中皂苷类化合物的含量为5.05g/L。本发明称之为“水香烟”烟液。
实施例9电子烟烟液的制备
(1)皂苷类化合物的制备：按照质量比为1:1:1，分别取人参皂苷Rb1、人参皂苷Rc、人参皂苷Rd(来源于成都汉禾生化制品有限公司)，混合均匀，即得。
(2)合成香料的制备：按照质量比为1:5:0.5:2:2:2:4:4:4；分别取香豆素、芸香苷、槲皮素、绿原酸、异戊酸、β-甲基戊酸、香叶醛、儿茶酚、茄尼醇，混合均匀，即得。
(3)电子烟烟液的制备：取所得皂苷类化合物66份、所得合成香料1份、去离子水15份、丙二醇70份、山梨醇11.5份，混合均匀、充分溶解，即得电子烟烟液100mL，所得电子烟烟液中皂苷类化合物的含量为660g/L。本发明称之为“水香烟”烟液。
实施例10电子烟烟液的制备
(1)烟草提取物的制备：将烟叶于40℃下烘干，冷却至室温，粉碎，与4倍体积的去离子水混合，30℃浸泡，不定期搅拌，40小时后抽滤，减压浓缩至1/2体积，得到烟叶提取物。
(2)电子烟烟液的制备：取人参皂苷Re(来源于成都汉禾生化制品有限公司)1份(每份1g)、所得烟叶提取物25份、丙二醇65份、山梨醇6.7份，混合均匀、充分溶解，即得电子烟烟液100mL，所得电子烟烟液中皂苷类化合物的含量为10g/L。本发明称之为“水香烟”烟液。
实施例11电子烟烟液的质量评价
对照组电子烟烟液的获得：
(1)烟叶提取物的制备：将烟叶于40℃下烘干，冷却至室温，粉碎，与5倍体积的去离子水混合，15℃浸泡，不定期搅拌，48小时后抽滤，减压浓缩至1/2体积，得到烟叶提取物。
(2)电子烟烟液的制备：取所得烟叶提取物20份、丙三醇11.5份、丙二醇65份，混合均匀、充分溶解，即得。
分别取实施例1至实施例10、制备获得的电子烟烟液、对照组提供的电子烟烟液。
感官质量评价实验：
由本发明实施例1至实施例10制备获得的电子烟烟液制成的电子烟作为实验组，以不添加花旗参提取物的电子烟烟液制成的电子烟作为对照组。所得电子烟样品由国内具有国家或省级卷烟感官质量评吸资格证书的20位专业技术人员进行评吸，进而进行感官质量评价考核，感官质量评价标准见表1。评吸试验结果见表2。
表1 电子烟感官质量评价标准
Figure PCTCN2015088730-appb-000001
表2 评吸试验结果
项目 香气 谐调 刺激性 余味 烟雾量 合计
对照组 24.46 4.75 16.10 21.15 8 74.46
实施例1 31.56 5.35 19.90 24.15 8.35 89.31
实施例2 30.15 4.85 19.60 23.05 8.30 85.95
实施例3 31.30 5.15 19.00 24.15 8 87.60
实施例4 30.85 5.20 18.75 23.55 8 86.35
实施例5 30.55 5.45 19.00 23.70 8 86.70
实施例6 31.20 5.15 18.60 24.00 8 86.95
实施例7 31.60 5.25 18.55 23.90 8 87.30
实施例8 30.15 5.55 18.95 23.45 8 86.10
实施例9 29.75 4.75 18.95 23.40 8.20 85.05
实施例10 30.25 5.65 18.25 24.00 8 86.15
根据实验结果可知，相比对照组，实验组的电子烟产品(即由本发明实施例1至实施例10制备获得的电子烟烟液制成的电子烟)的香气、余味得到了进一步的提升，而刺激性显著减小，差异显著(P＜0.05)，明显改善了电子烟对咽喉的刺激性。相比烟雾量，对照组与实验组实验结果相当，说明在电子烟烟液中添加花旗参提取物不影响雾化效果。
综上所述，本发明提供的电子烟烟液雾化效果好、口感纯正、显著减小了对咽喉的刺激性。
电子烟烟液对人体正常机能的影响：
取由本发明实施例1制备获得的电子烟烟液制成的电子烟，考察其对人体正常机能的影响。
在全国东北、华北、西南地区选取吸卷烟三年以上，且最近3个月平均每天吸0.5～2包卷烟的烟民150人，提供实施例1提供的制备方法制备获得的电子烟烟液制成的电子烟。使用方法相同：受试者每天1.5mL，连续使用3个月。分别在使用本发明提供的电子烟之前和使用3个月之后检测受试者的与心血管系统、血液系统、抗氧化能力相关的指标：血压、总胆固 醇、甘油三脂、低密度脂蛋白、高密度脂蛋白、丙二醛、超氧化物歧化酶、谷胱甘肽过氧化物酶、过氧化脂质。同时检测巨噬细胞数量与功能、进行体外淋巴细胞增殖试验以检验机体免疫力。
结果显示，经使用本发明提供的电子烟烟液后，94.67％受试者的血压(血压指标)有显著改善(P＜0.05)；90.67％受试者的血脂(总胆固醇、甘油三脂、低密度脂蛋白、高密度脂蛋白指标)有显著改善(P＜0.05)；92％受试者体内的抗氧化能力(丙二醛、超氧化物歧化酶、谷胱甘肽过氧化物酶、过氧化脂质指标)有显著提高(P＜0.05)。受试者体内巨噬细胞数量与功能检测试验、体外淋巴细胞增殖试验结果显示，受试者的免疫力获得显著提高(P＜0.05)。
取实施例2至实施例10制备获得的电子烟烟液制成的电子烟，按照相同的实验方法，考察本发明提供的电子烟烟液对人体正常机能的影响，获得了类似的实验结果，即经使用本发明实施例2至实施例10制备获得的电子烟烟液后，受试者的血压有显著改善、血脂得到显著改善、抗氧化能力显著提高，综合免疫力得到显著提高。
因此，利用本发明提供的电子烟烟液制备而得的电子烟长期使用，可降血压、降血脂、抗疲劳、延缓衰老，达到提高综合免疫力的功效。
以上对本发明所提供的电子烟烟液及包含该烟液的电子烟进行了详细介绍。本文应用了具体个例对本发明的原理及实施方式进行了阐述，以上实施例的说明只是用于帮助理解本发明的方法及其核心思想。应当指出，对于本技术领域技术人员来说，在不脱离本发明原理的前提下，还可以对本发明进行若干改进和修饰，这些改进和修饰也落入本发明权利要求的保护范围内。

Claims (9)

  1. 一种电子烟烟液，其特征在于，其包括皂苷类化合物、烟草香料和溶剂。
  2. 根据权利要求1所述的电子烟烟液，其特征在于，所述皂苷类化合物为人参皂苷Ra1、人参皂苷Ra2、人参皂苷Ra3、人参皂苷Rb1、人参皂苷Rb2、人参皂苷Rc、人参皂苷Rd、人参皂苷Re、人参皂苷Rf、人参皂苷Rg1、人参皂苷Rg2、人参皂苷Rg3、人参皂苷Rh1、人参皂苷Rh2、人参皂苷Rs1、人参皂苷Rs2、人参皂苷Rs3、人参皂苷F1、人参皂苷F2、人参皂苷F3、人参皂苷F5、人参皂苷R0、人参皂苷IH901、人参皂苷RAO或拟人参皂苷F11中的一种或两者以上混合物。
  3. 根据权利要求1或2所述的电子烟烟液，其特征在于，所述皂苷类化合物由花旗参提取物提供。
  4. 根据权利要求1至3中任一项所述的电子烟烟液，其特征在于，其中所述皂苷类化合物的含量为0.734g/L～660g/L。
  5. 根据权利要求1所述的电子烟烟液，其特征在于，所述烟草香料为烟草提取物和/或合成香料。
  6. 根据权利要求5所述的电子烟烟液，其特征在于，所述合成香料由香豆素、芸香苷、槲皮素、绿原酸、异戊酸、β-甲基戊酸、香叶醛、儿茶酚、茄尼醇组成。
  7. 根据权利要求1所述的电子烟烟液，其特征在于，所述溶剂为山梨醇、丙三醇、丙二醇、水中的一种或两者以上混合物。
  8. 根据权利要求1至7中任意一项所述的电子烟烟液，其特征在于，其包括0.0734～66重量份的所述皂苷类化合物、1～70重量份的所述烟草香料、26.7～96.5重量份的所述溶剂。
  9. 一种电子烟，其特征在于，其包括以下构件：烟杆、雾化器、电池组件；如权利要求1至8中任意一项所述的电子烟烟液放置于所述雾化器之中。
PCT/CN2015/088730 2014-09-03 2015-09-01 一种电雾化水香烟烟液及包含该烟液的电雾化水香烟 WO2016034100A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410445720.9A CN104336777B (zh) 2014-09-03 2014-09-03 一种可以提高人体免疫力的电雾化水香烟烟液及包含该烟液的电雾化水香烟
CN201410445720.9 2014-09-03

Publications (1)

Publication Number Publication Date
WO2016034100A1 true WO2016034100A1 (zh) 2016-03-10

Family

ID=52493849

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/088730 WO2016034100A1 (zh) 2014-09-03 2015-09-01 一种电雾化水香烟烟液及包含该烟液的电雾化水香烟

Country Status (2)

Country Link
CN (1) CN104336777B (zh)
WO (1) WO2016034100A1 (zh)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3260122A1 (en) * 2016-06-22 2017-12-27 Intelligent Synthetic Biology Center Composition for enhancing immunity including ginsenoside f1 as an active ingredient
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US10045568B2 (en) 2013-12-23 2018-08-14 Juul Labs, Inc. Vaporization device systems and methods
US10045567B2 (en) 2013-12-23 2018-08-14 Juul Labs, Inc. Vaporization device systems and methods
US10058130B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
US10104915B2 (en) 2013-12-23 2018-10-23 Juul Labs, Inc. Securely attaching cartridges for vaporizer devices
US10111470B2 (en) 2013-12-23 2018-10-30 Juul Labs, Inc. Vaporizer apparatus
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
US10512282B2 (en) 2014-12-05 2019-12-24 Juul Labs, Inc. Calibrated dose control
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
US10865001B2 (en) 2016-02-11 2020-12-15 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
CN113349411A (zh) * 2021-07-08 2021-09-07 北京诚品快拍物联网科技股份有限公司 一种电子烟的烟液用植物提取物复配香料及电子烟的烟液
US11134722B2 (en) 2013-11-12 2021-10-05 Vmr Products Llc Vaporizer
CN113729262A (zh) * 2021-09-17 2021-12-03 红云红河烟草(集团)有限责任公司 一种电子烟烟油配方及电子烟烟油的制备方法
CN113854623A (zh) * 2021-10-28 2021-12-31 中科分子生物(广东)股份有限公司 一种不含尼古丁盐的本草低温雾化电子烟烟油
WO2023116047A1 (en) * 2021-12-22 2023-06-29 Shenzhen Fumiao Biotechnology Co., Ltd Water-based atomizing agent, water-based atomizing substance for specified purpose, cartomizer and atomizing device

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104336777B (zh) * 2014-09-03 2016-11-16 美国豪顿水香烟科技（香港）有限公司 一种可以提高人体免疫力的电雾化水香烟烟液及包含该烟液的电雾化水香烟
CN105011352B (zh) * 2015-08-06 2016-06-01 云南中烟工业有限责任公司 一种绿茶香型电子烟烟油
CN105146733A (zh) * 2015-08-13 2015-12-16 深圳市施美乐科技股份有限公司 具有抗衰老功效的电子烟雾化液及其制备方法
CN105268007A (zh) * 2015-10-23 2016-01-27 吕其镁 烟友粉剂
CN105341995A (zh) * 2015-10-27 2016-02-24 深圳瀚星翔科技有限公司 电子烟烟液及其制备方法
CN105394808A (zh) * 2015-12-17 2016-03-16 立场电子科技发展（上海）有限公司 一种电子烟雾化液
CN108208916B (zh) * 2018-01-12 2020-09-11 吉林烟草工业有限责任公司 一种烟草制品及其制备方法
CN109619656A (zh) * 2019-01-18 2019-04-16 薪火高科(深圳)有限公司 一种具有消炎抗菌功效的电子烟烟液
WO2021102652A1 (zh) * 2019-11-25 2021-06-03 深圳雾芯科技有限公司 电子烟液
CN111802687B (zh) * 2020-07-27 2022-04-29 湖北中烟工业有限责任公司 含共轭亚油酸、皂苷的雾化剂以及加热不燃烧卷烟
CN113854624A (zh) * 2021-11-05 2021-12-31 上海纳米技术及应用国家工程研究中心有限公司 一种含三萜皂苷电子烟液及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1994159A (zh) * 2006-12-15 2007-07-11 姜志荣 电子雾化香烟用健肾醒脑烟液
CN102551218A (zh) * 2012-01-20 2012-07-11 易侧位 一种寿命延长的快速戒烟雾化烟
US20140150785A1 (en) * 2012-12-05 2014-06-05 Vire, L.L.C. Electronic cigarette or inhaler
CN104336777A (zh) * 2014-09-03 2015-02-11 美国豪顿水香烟科技（香港）有限公司 一种可以提高人体免疫力的电雾化水香烟烟液及包含该烟液的电雾化水香烟

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101884785B (zh) * 2010-05-28 2012-07-25 蒋金媛 酶解卵白蛋白复配口服液

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1994159A (zh) * 2006-12-15 2007-07-11 姜志荣 电子雾化香烟用健肾醒脑烟液
CN102551218A (zh) * 2012-01-20 2012-07-11 易侧位 一种寿命延长的快速戒烟雾化烟
US20140150785A1 (en) * 2012-12-05 2014-06-05 Vire, L.L.C. Electronic cigarette or inhaler
CN104336777A (zh) * 2014-09-03 2015-02-11 美国豪顿水香烟科技（香港）有限公司 一种可以提高人体免疫力的电雾化水香烟烟液及包含该烟液的电雾化水香烟

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HUANG, YULING.: "Hooton 5S Enjoy Vaping & Quit Smoking Eco-action", SCIENTIFIC EXPERIMENTIN IN COUNTRYSIDE, 10 July 2014 (2014-07-10), pages 42 - 43, ISSN: 2096-0743 *

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
US10638792B2 (en) 2013-03-15 2020-05-05 Juul Labs, Inc. Securely attaching cartridges for vaporizer devices
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
US11134722B2 (en) 2013-11-12 2021-10-05 Vmr Products Llc Vaporizer
US10264823B2 (en) 2013-12-23 2019-04-23 Juul Labs, Inc. Vaporization device systems and methods
US10058124B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
US10058130B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10070669B2 (en) 2013-12-23 2018-09-11 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
US10104915B2 (en) 2013-12-23 2018-10-23 Juul Labs, Inc. Securely attaching cartridges for vaporizer devices
US10111470B2 (en) 2013-12-23 2018-10-30 Juul Labs, Inc. Vaporizer apparatus
US10117465B2 (en) 2013-12-23 2018-11-06 Juul Labs, Inc. Vaporization device systems and methods
US10117466B2 (en) 2013-12-23 2018-11-06 Juul Labs, Inc. Vaporization device systems and methods
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10201190B2 (en) 2013-12-23 2019-02-12 Juul Labs, Inc. Cartridge for use with a vaporizer device
US11752283B2 (en) 2013-12-23 2023-09-12 Juul Labs, Inc. Vaporization device systems and methods
US10912331B2 (en) 2013-12-23 2021-02-09 Juul Labs, Inc. Vaporization device systems and methods
US10701975B2 (en) 2013-12-23 2020-07-07 Juul Labs, Inc. Vaporization device systems and methods
US10045567B2 (en) 2013-12-23 2018-08-14 Juul Labs, Inc. Vaporization device systems and methods
US10667560B2 (en) 2013-12-23 2020-06-02 Juul Labs, Inc. Vaporizer apparatus
US10045568B2 (en) 2013-12-23 2018-08-14 Juul Labs, Inc. Vaporization device systems and methods
US10512282B2 (en) 2014-12-05 2019-12-24 Juul Labs, Inc. Calibrated dose control
US10865001B2 (en) 2016-02-11 2020-12-15 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
USD929036S1 (en) 2016-06-16 2021-08-24 Pax Labs, Inc. Vaporizer cartridge and device assembly
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD913583S1 (en) 2016-06-16 2021-03-16 Pax Labs, Inc. Vaporizer device
US10682366B2 (en) 2016-06-22 2020-06-16 Intelligent Synthetic Biology Center Method for enhancing immunity using ginsenoside F1 as an active ingredient
EP3260122A1 (en) * 2016-06-22 2017-12-27 Intelligent Synthetic Biology Center Composition for enhancing immunity including ginsenoside f1 as an active ingredient
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
CN113349411A (zh) * 2021-07-08 2021-09-07 北京诚品快拍物联网科技股份有限公司 一种电子烟的烟液用植物提取物复配香料及电子烟的烟液
CN113729262A (zh) * 2021-09-17 2021-12-03 红云红河烟草(集团)有限责任公司 一种电子烟烟油配方及电子烟烟油的制备方法
CN113854623A (zh) * 2021-10-28 2021-12-31 中科分子生物(广东)股份有限公司 一种不含尼古丁盐的本草低温雾化电子烟烟油
WO2023116047A1 (en) * 2021-12-22 2023-06-29 Shenzhen Fumiao Biotechnology Co., Ltd Water-based atomizing agent, water-based atomizing substance for specified purpose, cartomizer and atomizing device

Also Published As

Publication number Publication date
CN104336777B (zh) 2016-11-16
CN104336777A (zh) 2015-02-11

Similar Documents

Publication Publication Date Title
WO2016034100A1 (zh) 一种电雾化水香烟烟液及包含该烟液的电雾化水香烟
CN102960852B (zh) 淡雅香型电子烟雾化烟液及其制备方法
WO2019100545A1 (zh) 低温烟及其制备方法
WO2021036121A1 (zh) 电子烟液
US20230071441A1 (en) Cigarette filter containing natural plant material, preparation method thereof, and cigarette including the filter
CN101444331B (zh) 金银花、野菊花、桑叶的超高压提取法及其提取液的应用
WO2021036122A1 (zh) 电子烟液
CN106867675A (zh) 一种烟用罗汉果香精的制备方法
CN102793264A (zh) 玉兰花果实提取物的制备方法及其在卷烟中的应用
CN111000283A (zh) 一种用于气溶胶装置的电子烟油及其制备方法和应用
CN104397871A (zh) 一种含茶叶提取物的电子烟烟油及其制备方法
CN104585864B (zh) 一种含沙棘多糖的电子烟烟液
CN110982625A (zh) 一种香烟滤嘴用甘草味干珠及其制备方法
CN104705777B (zh) 一种含天然复配物的电子烟烟液
CN108158030A (zh) 一种复合中药提取物提取方法及其在卷烟中的应用
CN110638082A (zh) 一种适用于加热非燃烧烟的调配物及其制取工艺
WO2005110129A1 (fr) Filtre a cigarettes ecologique et sans danger pour la sante
CN103768367B (zh) 一种祛痰止咳型烟草口腔喷剂及其制备方法
CN113749277B (zh) 一种具有龙涎香香气的雾化液及其制备方法
CN109043641A (zh) 沉香叶和沉香油混合的卷烟及其制作工艺
CN113397198A (zh) 一种留香持久的草莓味电子烟烟油及其制备方法
CN103549651A (zh) 一种具有镇咳功效的减毒香烟
CN112870247A (zh) 一种有利于咽喉健康的功能性电子烟烟油
CN113057369A (zh) 一种纸质滤棒及其制备方法
CN104687242A (zh) 从鸡蛋花中提取(R)-3-羧基-α-羟基苯丙酸的方法、应用及香烟

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15838613

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15838613

Country of ref document: EP

Kind code of ref document: A1